Jump to ContentJump to Main Navigation
Science, the State, and the CityBritain's Struggle to Succeed in Biotechnology$
Users without a subscription are not able to see the full content.

Geoffrey Owen and Michael M. Hopkins

Print publication date: 2016

Print ISBN-13: 9780198728009

Published to Oxford Scholarship Online: May 2016

DOI: 10.1093/acprof:oso/9780198728009.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2020. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 28 October 2020

A Second Chance for UK Biotech

A Second Chance for UK Biotech

Chapter:
(p.114) 5 A Second Chance for UK Biotech
Source:
Science, the State, and the City
Author(s):

Geoffrey Owen

Michael M. Hopkins

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780198728009.003.0005

In the immediate aftermath of the financial crisis, the flow of bad news from the UK biotech sector continued, with several corporate collapses reinforcing the reluctance of investors and their financial advisers to put money into biotech firms. By 2014, however, the clouds were beginning to lift, thanks in part to the booming demand for biotech stocks on NASDAQ; the resurgent enthusiasm for the sector among US investors began to spread across the Atlantic, allowing several European firms to float their shares on their local exchanges. In the UK the flotation of Circassia on the LSE’s main market—the first such IPO since 2006—was followed by several more flotations, mostly on AIM. At the same time there was an encouraging increase in venture capital funding for unquoted firms.

Keywords:   Circassia, recovery, institutional investors, NASDAQ, government policy

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .